PanOptix Trifocal IOL Surpasses One Million Implants Worldwide
Alcon announced that the AcrySof IQ PanOptix Trifocal IOL has surpassed more than 1 million implants worldwide.2 To mark this milestone, Alcon is launching a new “One Million Moments – Thank You” ad campaign that recognizes the positive impact eye care professionals (ECPs) have made on their patients who have been implanted with PanOptix. The campaign will bring to life thank you moments between a patient and ECP.1
“When we launched PanOptix, we knew that bringing this trifocal IOL to ophthalmologists around the world would have a significant impact on cataract patients,” Alex Long, Alcon’s Global Vice President of Cataract Implantables, said in a company news release. “In recognizing 1 million PanOptix implants, we want to say ‘thank you’ to the ophthalmology community for continuing to care for cataract patients around the world, helping deliver not only their need for restored vision, but also vision correction to support their lifestyle needs and preferences. The impact this IOL continues to have on patients’ lives and the testimonials we have received through the years inspire us to continue to help even more patients see brilliantly.”
The impact of PanOptix was recently recognized with Alcon receiving the “Best Medical Technology” award for the 50th Prix Galien USA. Prix Galien honors innovations that improve the human condition. This is the latest award for PanOptix, which has won other accolades in the past, including the “Business Intelligence Group (BIG) Innovation” award.
PanOptix IOL utilizes advanced Enlighten Optical Technology, a proprietary design that optimizes intermediate vision without compromising exceptional near and distance vision. The Enlighten technology allows people to see better in both bright and dim conditions – both day and night – by providing a meaningful high total light utilization.3
References
- AcrySof® IQ PanOptix® Directions for Use.
- Promotional Claim Supporting information PanOptix PC-IOL Family Product Code TFNT00.
- Groessl EJ, Liu L. Sklar M, Tally SR, Kaplan RM, Ganiats TG. Measuring the impact of cataract surgery on generic and vision-specific quality of life. Qual Life Res. 2013;22(6):1405-1414. Doi:10.1007/s11136-012-0270-z.